HIV-2-Infected Macrophages Produce and Accumulate Poorly Infectious Viral Particles

被引:4
|
作者
Gea-Mallorqui, Ester [1 ,3 ]
Zablocki-Thomas, Laurent [1 ]
Maurin, Mathieu [1 ]
Jouve, Mabel [2 ]
Rodrigues, Vasco [1 ]
Ruffin, Nicolas [1 ]
Benaroch, Philippe [1 ]
机构
[1] PSL Res Univ, Inst Curie, INSERM, U932, Paris, France
[2] PSL Res Univ, Inst Curie, UMR3216, Paris, France
[3] Univ Oxford, Nuffield Dept Med, Oxford, England
来源
FRONTIERS IN MICROBIOLOGY | 2020年 / 11卷
关键词
macrophages; HIV-2; viral assembly; virus-containing compartment; restriction factors; HIV transmission to T cells; viral reservoir; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-2; INFECTION; HIV-1-INFECTED MACROPHAGES; T-CELLS; RELEASE; INHIBITION; SAMHD1; PHAGOCYTOSIS; COMPARTMENTS; ENDOSOMES;
D O I
10.3389/fmicb.2020.01603
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A significant proportion of HIV-2-infected patients exhibit natural virological control that is generally absent from HIV-1-infected patients. Along with CD4(+)T cells, HIV-1 targets macrophages which may contribute to viral spreading and the latent reservoir. We have studied the relationship between macrophages and HIV-2, focusing on post-entry steps. HIV-2-infected monocyte-derived macrophages (MDMs) produced substantial amounts of viral particles that were largely harbored intracellularly. New viruses assembled at the limiting membrane of internal compartments similar to virus-containing compartments (VCCs) described for HIV-1. VCCs from MDMs infected with either virus shared protein composition and morphology. Strikingly, HIV-2 Gag was mostly absent from the cytosol and almost exclusively localized to the VCCs, whereas HIV-1 Gag was distributed in both locations. Ultrastructural analyses of HIV-2-infected MDMs revealed the presence of numerous VCCs containing both immature and mature particles in the lumen. HIV-2 particles producedde novoby MDMs were poorly infectious in reporter cells and in transmission to activated T cells through a process that appeared independent of BST2 restriction. Rather than being involved in viral spreading, HIV-2-infected macrophages may represent a cell-associated source of viral antigens that can participate in the immune control of HIV-2 infection.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
    Peterson, Ingrid
    Togun, Oluwatoyin
    de Silva, Thushan
    Oko, Francis
    Rowland-Jones, Sarah
    Jaye, Assan
    Peterson, Kevin
    AIDS, 2011, 25 (17) : 2167 - 2175
  • [22] The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals
    Hangxing Yu
    Shariq M Usmani
    Alexandra Borch
    Julia Krämer
    Christina M Stürzel
    Mohammad Khalid
    Xuehua Li
    Daniela Krnavek
    Marchina E van der Ende
    Albert D Osterhaus
    Rob A Gruters
    Frank Kirchhoff
    Retrovirology, 10
  • [23] PML-IRIS in an HIV-2-infected patient presenting as Bell’s palsy
    Fabian Sierra Morales
    Carlos Illingworth
    Kathie Lin
    Ivia Rivera Agosto
    Chloé Powell
    Jacob A. Sloane
    Igor J. Koralnik
    Journal of NeuroVirology, 2017, 23 : 789 - 792
  • [24] Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas
    Kempf, W
    Margolin, DH
    Dezube, BJ
    Kadin, ME
    Letvin, NL
    Koralnik, IJ
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 65 (04) : 302 - 306
  • [25] Efavirenz Loaded Nanostructured Lipid Carriers for Efficient and Prolonged Viral Inhibition in HIV-Infected Macrophages
    Mahajan, Ketan
    Rojekar, Satish
    Desai, Dipen
    Kulkarni, Smita
    Vavia, Pradeep
    PHARMACEUTICAL SCIENCES, 2021, 27 (03) : 418 - 432
  • [26] Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients
    Benard, Antoine
    Damond, Florence
    Campa, Pauline
    Peytavin, Gilles
    Descamps, Diane
    Lascoux-Combes, Caroline
    Taieb, Audrey
    Simon, Francois
    Autran, Brigitte
    Brun-Vezinet, Francoise
    Chene, Genevieve
    Matheron, Sophie
    AIDS, 2009, 23 (09) : 1171 - 1173
  • [27] Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient
    Wandeler, Gilles
    Furrer, Hansjakob
    Rauch, Andri
    AIDS, 2011, 25 (18) : 2306 - 2308
  • [28] Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers
    Angin, Mathieu
    Wong, Glenn
    Papagno, Laura
    Versmisse, Pierre
    David, Annie
    Bayard, Charles
    Charmeteau-De Muylder, Benedicte
    Besseghir, Amel
    Thiebaut, Rodolphe
    Boufassa, Faroudy
    Pancino, Gianfranco
    Sauce, Delphine
    Lambotte, Olivier
    Brun-Vezinet, Francoise
    Matheron, Sophie
    Rowland-Jones, Sarah L.
    Cheynier, Remi
    Saez-Cirion, Asier
    Appay, Victor
    JOURNAL OF IMMUNOLOGY, 2016, 197 (07) : 2787 - 2795
  • [29] A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1-and HIV-2-Infected Nonprogressors
    Diallo, Mariama Sadjo
    Samri, Assia
    Charpentier, Charlotte
    Bertine, Melanie
    Cheynier, Remi
    Thiebaut, Rodolphe
    Matheron, Sophie
    Collin, Fideline
    Braibant, Martine
    Candotti, Daniel
    Brun-Vezinet, Francoise
    Autran, Brigitte
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (03) : 214 - 223
  • [30] Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients
    van der Ende, ME
    Prins, AM
    Brinkman, K
    Keuter, M
    Veenstra, A
    Danner, SA
    Niesters, HGM
    Osterhaus, ADME
    Schutten, M
    AIDS, 2003, 17 : S55 - S61